Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002

A Phase 1, Open-Label,Single Radiolabeled Dose Study to Investigate the Absorption, Metabolism and Excretion of [14C]-ETC-1002 in Healthy Male Volunteers

This Phase 1 study will assess the mass balance recover of carbon-14 (14C) labelled ETC-1002 and the routes and rates of excretion of [14C]-ETC-1002

Inclusion Criteria:

• Healthy Male Volunteers
• BMI 10-35 kg/m2

Exclusion Criteria:

• Hx of CV, renal, hepatic, chronic respiratory or GI disease
• Hx of drug or alcohol abuse
• smoking within 12 mos of screening